LRRC4 and rosacea: We then injected cathelicidin LL37 intradermally into wild-type (WT) mice and Lrrc4 mutant mice, including heterozygotes (HET) and homozygotes (HOM), to induce rosacea-like mouse models as previously described7,32, and compared the resulting rosacea-like phenotypes at different timepoints.